Aquestive Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Aquestive Therapeutics

07/08/2023 23:01

* Aquestive Therapeutics Inc  AQST.OQ  reported a quarterly
adjusted loss of 10 cents​​ per share for the quarter ended in
June. The mean expectation of six analysts for the quarter was
for a loss of 12 cents per share.
    * Revenue fell 0.2% to $13.24 million from a year ago;
analysts
expected $11.01 million. 
    * Aquestive Therapeutics Inc's reported EPS for the quarter
was a
loss of 10 cents​.
    * The mean earnings estimate of analysts had fallen by
about 2.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Aquestive Therapeutics Inc shares had risen by 26.7% this
quarter and gained 131.7% so far this year.
    * The company reported a quarterly loss of $5.79 million.
    * Wall Street's median 12-month price target for Aquestive
Therapeutics Inc is $6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 7 at 10:01 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.12          -0.10          Beat
 Mar. 31 2023      -0.19          -0.12          Beat
 Dec. 31 2022      -0.23          -0.23          Met
 Sep. 30 2022      -0.31          -0.23          Beat